A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis
Status:
Recruiting
Trial end date:
2024-08-31
Target enrollment:
Participant gender:
Summary
This study has been designed to explore the clinical efficacy and safety of HS-10374 in the
treatment of moderate to severe plaque psoriasis. Additionally, this study is to find the
optimal dosing for the future clinical development of HS-10374.